A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Hepatocellular Carcinoma
Clinical trial NCT07351513 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07351513
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-30
- Primary completion
- 2026-10-30
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.